These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9260552)

  • 1. Inhibition of lymphocyte function by head and neck carcinoma cell line soluble factors.
    Bailet JW; Lichtenstein A; Chen G; Mickel RA
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):855-62. PubMed ID: 9260552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First place--Resident Clinical Science Award 1990. Suppression of lymphokine-activated killer cell cytotoxicity by a soluble factor produced by squamous tumors of the head and neck.
    Strasnick B; Lagos N; Lichtenstein A; Mickel RA
    Otolaryngol Head Neck Surg; 1990 Oct; 103(4):537-49. PubMed ID: 2123311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of lymphokine-activated lymphocytes. Lysis of human head and neck squamous cell carcinoma cell lines.
    Alessi DM; Hutcherson RW; Mickel RA
    Arch Otolaryngol Head Neck Surg; 1989 Jun; 115(6):725-30. PubMed ID: 2785809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
    Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
    Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular calcium changes associated with in vitro lymphokine-activated killer and natural killer cell cytotoxicity.
    Burkey BB; Omann GM; Wolf GT
    Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1281-6. PubMed ID: 1747234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
    Wang MB; Lichtenstein A; Mickel RA
    Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer.
    Wanebo HJ; Blackinton D; Kouttab N; Mehta S
    Am J Surg; 1993 Oct; 166(4):389-94. PubMed ID: 8214299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of head and neck tumor cell colony growth by lymphokine activated killer cells.
    Kumazawa H; Kita J; Sai S; Tachikawa T; Hori Y; Yamazaki N; Yamashita T; Kumazawa T; Kawamoto K; Koldovsky P
    Acta Otolaryngol Suppl; 1993; 500():138-41. PubMed ID: 8452012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer.
    Bugis SP; Lotzová E; Savage HE; Hester JP; Racz T; Sacks PG; Schantz SP
    Cancer Immunol Immunother; 1990; 31(3):176-81. PubMed ID: 2337906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of the lymphokine-activated killer cell response in head and neck cancer patients by combination interleukin-2 and interferon-alpha.
    Wanebo H; Blackinton D; Weigel T; Turk P; Mehta S
    Am J Surg; 1991 Oct; 162(4):384-7. PubMed ID: 1951894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.
    Hirabayashi H; Yasumura S; Lin WC; Amoscato A; Johnson JT; Herberman RB; Whiteside TL
    Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):285-92. PubMed ID: 7873144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killing of autologous and allogeneic short-term cultured head and neck squamous carcinomas.
    Leess FR; Bredenkamp JK; Lichtenstein A; Mickel RA
    Laryngoscope; 1989 Dec; 99(12):1255-61. PubMed ID: 2601539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulation of the induction phase of lymphokine-activated killer activity by acute phase proteins.
    Clayman GL; Liu FJ; Taylor DL; Savage HE; Lavedan P; Buchsbaum RM; Trujillo JM; Schantz SP
    Otolaryngol Head Neck Surg; 1991 Jul; 105(1):26-34. PubMed ID: 1715542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressed PMNC blastogenic response in patients with cancer of the head and neck: a study of IL-2 production, IL-2 consumption, and IL-2 receptor expression.
    Eskinazi DP; Perna JJ; Ershow AG; Mihail RC
    Laryngoscope; 1989 Feb; 99(2):151-7. PubMed ID: 2783615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.
    Clayman GL; Taylor DL; Liu FJ; Lavedan P; Savage HE; Schantz SP
    Laryngoscope; 1993 Mar; 103(3):299-307. PubMed ID: 7680086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
    Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
    Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck.
    Wanebo HJ; Jones T; Pace R; Cantrell R; Levine P
    Am J Surg; 1989 Oct; 158(4):356-60. PubMed ID: 2802041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma.
    Sadeghi N; Black MJ; Hier MP; Shenouda G; Karp SE
    Arch Otolaryngol Head Neck Surg; 1997 Jan; 123(1):25-30. PubMed ID: 9006500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine model for the immunotherapy of head and neck squamous cell carcinoma.
    Hier MP; Black MJ; Shenouda G; Sadeghi N; Karp SE
    Laryngoscope; 1995 Oct; 105(10):1077-80. PubMed ID: 7564839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.